inhaled mAChRs and ADRB2 agonist

Ph. I/II candidate in Asthma and COPD discontinued

soft drug design from previously disclosed lead MABA

J. Med. Chem.

Chiesi Farmaceutici S.p.A, Parma, IT

CHF-6366 Chemical Structure inhaled mAChRs and ADRB2 agonist - Chiesi Farmaceutici S.p.A, Parma, IT

Context. CHF-6366 (Chiesi Farmaceutici S.p.A) is a muscarinic antagonist and β2 agonist (MABA) being developed as an inhaled treatment for respiratory diseases. Muscarinic antagonists and β2 agonists both act…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: